Oncogenic mechanisms of the Helicobacter pylori CagA protein

Nature Reviews Cancer

Volumn 4, Issue 9, 2004, Pages 688-694

  Hatakeyama, Masanori ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN; PROTEIN TYROSINE PHOSPHATASE SHP 2; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CAGA PROTEIN, HELICOBACTER PYLORI; PROTEIN TYROSINE PHOSPHATASE; SIGNAL PEPTIDE; SRC HOMOLOGY 2 (SH2) DOMAIN CONTAINING PHOSPHATASES; SRC HOMOLOGY-2 (SH2) DOMAIN-CONTAINING PHOSPHATASES;

BACTERIAL STRAIN; BINDING SITE; CAGA GENE; CARCINOGENESIS; EPITHELIUM CELL; GENE; GENETIC VARIABILITY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STOMACH CARCINOMA; TUMOR PROMOTION; CARCINOMA; CELL TRANSFORMATION; DOWN REGULATION; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PHOSPHORYLATION; SRC HOMOLOGY DOMAIN; STOMACH TUMOR;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; DOWN-REGULATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PHOSPHORYLATION; PROTEIN-TYROSINE-PHOSPHATASE; SRC HOMOLOGY DOMAINS; STOMACH NEOPLASMS;

EID: 4544334936     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc1433     Document Type: Review

References (48)

1. Uemura, N. et al. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 345, 784-789 (2001). Provides compelling epidemiological evidence for the role of H. pylori in the development of gastric carcinoma.
2. Wong, B. C. et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 291, 187-194 (2004).
3. Cover, T. L. et al. Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supematants with vacuolizing cytotoxin activity. Infect. Immun. 58, 603-610 (1990).
4. Crabtree, J. E. et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 338, 332-335 (1991).
5. Covacci, A. et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc. Natl Acad. Sci. USA 90, 5791-6795 (1993).
6. Tummuru, M. K., Cover, T. L. & Blaser, M. J. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect. Immun. 61, 1799-1809 (1993).
7. Censini, S. et al. cag, a pathogenecity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl Acad. Sci. USA 93, 14648-14653 (1996).
8. Kuipers, E. J., Perez-Perez, G. I., Meuwissen, S. G. & Baser, M. J. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J. Natl Cancer Inst. 87, 1777-1780 (1995).
9. Blaser, M. J. et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res, 55, 2111-2115 (1995).
10. Personnel, J., Friedman, G. D., Orentreich, N. & Vogelman, H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 40, 297-301 (1997).
11. Segal, E. D., Cha, J., Lo, J., Falkow, S. & Tompkins, L. S. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc. Natl Acad. Sci. USA 96, 14559-14564 (1999).
12. Asahi, M. et al. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J. Exp. Med. 191, 593-602 (2000).
13. Stein, M., Rappuoli, R. & Covacci, A. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc. Natl Acad. Sci. USA 97, 1263-1268 (2000).
14. Odenbreit, S. et al. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287, 1497-1500 (2000).
15. Fischer, W. et al. Systematic mutagenesis of the Helicobacter pylori Gag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol. Microbiol. 42, 1337-1348 (2001).
16. Stein, M. et al. c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol. Microbiol. 43, 971-980 (2002).
17. Selbach, M., Moese, S., Hauck, C. R., Meyer, T. F. & Backert, S. Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J. Biol. Chem. 277, 6775-6778 (2002).
18. Higashi, H. et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 295, 683-686 (2002). The first demonstration that tyrosine-phosphotylated CagA specifically binds and activates SHP2 phosphatase in gastric epithelial cells.
19. Higashi, H. et al. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc. Natl Acad. Sci. USA 99, 14428-14433 (2002). Provides evidence that East-Asian CagA is biologically more active than Western CagA.
20. Backert, S., Moese, S., Selbach, M., Brinkmann, V. & Meyer, T. F. Phosphorylation of tyrosine 972 of the Helicobacter pylori CagA protein is essential for induction of a scattering phenotype in gastric epithelial cells. Mol. Microbiol. 42, 631-644 (2001).
21. Feng, G. S. & Pawson, T. Phosphotyrosine phosphatases with SH2 domains: regulators of signal transduction. Trends Genet. 10, 54-58 (1994).
22. Hof, P., Pluskey, S., Dhe-Paganon, S., Eok, M. J. & Shoelson, S. E. Crystal structure of the tyrosine phosphatase SHP-2. Cell 92, 441-450 (1998).
23. Van Vactor, D., O'Reilly, A. M. & Ned B. G. Genetic analysis of protein tyrosine phosphatases. Curr. Opin. Genet. Dev. 8, 112-126 (1998).
24. Yu, I. H., Qu, C. K., Henegariu, O., Lu, X. & Feng, G. S. Protein-tyrosine phosphatase Shp-2 regulates cell spreading, migration, and focal adhesion. J. Biol. Chem. 273, 21125-21131 (1998).
25. Manes, S. et al. Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility. Mol. Cell. Biol. 19, 3125-3135 (1999).
26. Maroun, C. R., Naujokas, M. A., Holgado-Madruga, M., Wong, A. J. & Park, M. The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase. Mol. Cell. Biol. 20, 8513-8525 (2000).
27. Tartaglia, M. et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nature Genet. 29, 465-468 (2001).
28. Tartaglia, M. et al. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nature Genet. 34, 148-150 (2003).
29. Loh, M. L. et al. Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis. Blood 103, 2325-2331 (2004). References 28 and 29 demonstrate gain-of-function mutations in SHP2 in human leukaemias.
30. Higashi, H. et al. Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation. J. Biol. Chem. 279, 17205-17216 (2004).
31. Higuchi, M., Tsutsumi, R., Higashi, H. & Hatakeyama, M. Conditional gene silencing utilizing the lac repressor reveals a role of SHP-2 in cagA-positive Helicobacter pylori pathogenicity. Cancer Sci. 95, 442-447 (2004).
32. Tsutsumi, R., Higashi, H., Higuchi, M., Okada, M. & Hatakeyama, M. Attenuation of Helicobacter pylori CagA-SHP-2 signaling by interaction between CagA and C-temninal Src kinase. J. Biol. Chem. 278, 3664-3670 (2003).
33. Selbach, M. et al. The Helicobacter pylori CagA protein induces cortactin dephosphorylation and actin rearrangement by c-Src inactivation. EMBO J. 22, 515-528 (2003).
34. Joneson, T. & Bar-Sagi, D. Suppression of Ras-induced apoptosis by the Rac GTPase. Mol. Cell. Biol. 19, 5892-5901 (1999).
35. Correa, P., Haenszel, W., Cuello, C., Tannenbaum, S. & Archer, M. A model for gastric cancer epidemiology. Lancet 2, 58-60 (1975).
36. Yamazaki, S. et al. The CagA protein of Helicobacter pylori translocated into epithelial cells and binds to SHP-2 in human gastric mucosa. J. Infect. Dis. 187, 334-337 (2003).
37. Hansson, L. E. et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N. Engl. J. Med. 335, 242-249 (1996).
38. Nomura, A. M., Perez-Perez, G. I., Lee, J., Stemmermann, G. & Blaser, M. J. Relation between Helicobacter pylori cagA status and risk of peptic ulcer disease. Am. J. Epidemiol. 155, 1054-1059 (2002).
39. El-Omar, E. M. et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124, 1193-1201 (2003).
40. De Souza, D. et al. SH2 domains from suppressor of cytokine signaling-3 and protein tyrosine phosphatase SHP-2 have similar binding specificities. Biochemistry 41, 9229-9236 (2002).
41. Azuma, T. et al. Association between diversity in the Src homology 2 domain-containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer. J. Infect. Dis. 189, 820-827 (2004).
42. Yamaoka Y. et al. Relationship between the cagA 3′ repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology 117, 342-349 (1999).
43. Judd, L. M. et al. Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130. Gastroenterology 126, 196-207 (2004). Reports the development of a mouse model of gastric carcinoma by expressing the interleukin-6 receptor gp130 that lacks the SHP2 binding site.
44. Mimuro, H. et al. Grb2 is a key mediator of Helicobacter pylori CagA protein activities. Mol. Cell 10, 745-55 (2002).
45. Churin, Y. et al. Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J. Cell Biol. 161, 249-255 (2003).
46. Amieva, M. R. et al. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 300, 1430-1434 (2003).
47. Gruenheid, S. et al. Enteropathogenic E. Coli Tir binds Nck to initiate actin pedestal formation in host cells. Nature Cell Biol. 3, 856-859 (2001).
48. Ye, W. et al. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J. Natl Cancer Inst. 96, 388-396 (2004).